D. Medical Rises to Week High as Canada Approves Health Solution
D. Medical Industries Ltd. climbed to the highest level in a week after the developer of drug-delivery devices said a unit received a license from Health Canada to sell its Spring Universal Infusion sets in that country.
The shares increased 4 percent to 16.46 shekels, the highest intraday level since May 8, as of 11:32 a.m. in Tel Aviv. That gives the Ramat Gan, Israel-based company a market value of 128 million shekels ($36 million).
To contact the reporter on this story: Ronit Goodman in Tel Aviv at email@example.com
To contact the editor responsible for this story: Claudia Maedler at firstname.lastname@example.org